Association of Chronic Kidney Disease With In-Hospital Outcomes of Transcatheter Aortic Valve Replacement

Tanush Gupta1, Kashish Goel2, Dhaval Kolte3

  • 1Division of Cardiology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York.

Insights

Patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD) face higher in-hospital mortality after transcatheter aortic valve replacement (TAVR). Acute kidney injury (AKI) also significantly increases mortality risk in TAVR patients.

Area of Science:

  • Cardiology
  • Nephrology
  • Medical Outcomes Research

Background:

  • Chronic kidney disease (CKD) is a known risk factor for poor outcomes in surgical valve replacement.
  • Limited data exists on CKD patients undergoing transcatheter aortic valve replacement (TAVR), particularly those on dialysis.

Purpose of the Study:

  • To investigate the association between chronic kidney disease (CKD) and in-hospital outcomes following transcatheter aortic valve replacement (TAVR).
  • To compare outcomes across patients with no CKD, CKD, and end-stage renal disease (ESRD) on dialysis undergoing TAVR.

Main Methods:

  • Utilized the 2012-2014 National Inpatient Sample database for patients aged ≥18 undergoing TAVR.
  • Classified patients into no CKD, CKD (without dialysis), and ESRD (on dialysis) groups using ICD-9-CM codes.
  • Employed multivariable logistic regression with generalized estimating equations to analyze in-hospital outcomes.

Main Results:

  • Higher in-hospital mortality was observed in CKD (4.5%) and ESRD (8.3%) groups compared to no CKD (3.8%).
  • CKD and ESRD patients experienced increased rates of major adverse cardiovascular events, net adverse cardiovascular events, and pacemaker implantation.
  • Acute kidney injury (AKI) and AKI requiring dialysis were linked to substantially higher in-hospital mortality, with no decline in AKI incidence over the study period.

Conclusions:

  • CKD and ESRD are associated with significantly worse in-hospital outcomes after TAVR.
  • Acute kidney injury (AKI) poses a substantial mortality risk for TAVR patients, and its incidence remains a concern.
  • The findings highlight the importance of considering renal function in TAVR patient management and risk stratification.
Abstract

Related Concept Videos

Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
1.6K
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
362
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
1.3K
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
1.0K
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
851
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
626